Table 4.
Opioid types used by enrollees with non-cancer pain conditions (NCPC) who used opioids according to DEA schedule and duration of action for Arkansas Medicaid and HealthCore members: 2000 vs. 2005
| Opioid Types | HealthCore 2000 N= 146530 | HealthCore 2005 N= 322123 | % Change 2000-2005 | Medicaid 2000 N= 23155 | Medicaid 2005 N= 35697 | % Change 2000-2005 | |
|---|---|---|---|---|---|---|---|
| Short-Acting Schedule II Users Per Yeara | % | 12.4% | 18.8% | 52.0% | 13.3% | 17.5% | 31.2% |
| Mean Total Yearly Dose Per Short-Acting Schedule II NCPC opioid userb | Mean (SD) | 1,345.6 (10,190.0) | 2,631.2 (21,897.3) | 95.5% | 1,528.1 (5,360.6) | 4,450.3 (11,484.4) | 191.2% |
| [Median] | [300] | [300] | [300] | [465] | |||
| Short-Acting Schedule II Proportion of Cumulative yearly opioid dose among all NCPC opioid usersc | Mean (SD) | 7.2% (23.3%) | 11.0% (27.8%) | 54.0% | 5.4% (19.2%) | 7.4% (23.2%) | 38.3% |
| Long-Acting Schedule II Users Per Yeara | % | 4.0% | 4.7% | 19.5% | 6.6% | 9.3% | 40.8% |
| Mean Total Yearly Dose Per Long-Acting Schedule II NCPC opioid userb | Mean (SD) | 20,936.8 (44,365.4) | 29,155.7 (54,450.7) | 39.3% | 24,479.8 (38,031.7) | 29,722.9 (41,288.1) | 21.4% |
| [Median] | [3,600] | [8,400] | [10,035] | [14,700] | |||
| Long-Acting Schedule II Proportion of Cumulative yearly opioid dose among all NCPC opioid usersc | Mean (SD) | 2.5% (13.7%) | 2.8% (14.1%) | 11.2% | 4.4% (18.5%) | 6.1% (21.1%) | 37.2% |
| Schedule III-IV Opioid Users Per Yeara | % | 94.3% | 92.4% | -2.0% | 95.4% | 94.2% | -1.3% |
| Mean Total Yearly Dose Per Schedule III-IV NCPC opioid userb | Mean (SD) | 1,493.1 (3,738.0) | 1,503.5 (3,625.4) | 0.7% | 3,401.5 (5,892.9) | 3,630.4 (5,624.5) | 6.7% |
| [Median] | [338] | [340] | [1011] | [1,250] | |||
| Schedule III-IV Opioids Proportion of Cumulative yearly opioid dose among all NCPC opioid usersc | Mean(SD) | 90.3% (27.0%) | 86.1% (31.2%) | -4.7% | 90.2% (26.5%) | 86.5% (30.5%) | -4.1% |
a
Proportion of all enrollees receiving a NCPC diagnosis and opioids in a calendar year who received this type of opioid
b
Mean total dose (in mg morphine equivalents) of this opioid type received in a calendar year by NCPC enrollees receiving that opioid type that year
c
Proportion of cumulative yearly opioid dose (in mg morphine equivalents) received by enrollees with a NCPC diagnosis that is of this type of opioid